Other OTC Pharmaceuticals - Cyprus

  • Cyprus
  • In Cyprus, the revenue generated in the Other OTC Pharmaceuticals market reached US$21.11m in 2024.
  • It is projected to experience an annual growth rate of 1.48% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,171.00m in 2024.
  • Taking into account the total population figures, per person revenues in Cyprus amounted to US$16.65 in 2024.
  • In Cyprus, there is a growing trend towards natural and herbal remedies in the Other OTC Pharmaceuticals market.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Cyprus has been experiencing steady growth in recent years. Customer preferences in the market have been driven by a growing demand for self-medication options and a preference for convenience. Consumers are increasingly looking for over-the-counter products that can provide relief from common ailments such as cold and flu symptoms, allergies, and digestive issues. They are also seeking products that are easy to use and readily available without a prescription. This trend is in line with the global market, where consumers are becoming more proactive in managing their own health and wellness.One of the key trends in the market is the increasing availability and variety of OTC pharmaceutical products. Pharmacies and drugstores in Cyprus are expanding their product offerings to meet the growing demand from consumers. This includes a wider range of OTC medications, as well as complementary products such as vitamins, supplements, and herbal remedies. The market is also seeing an increase in the availability of generic OTC medications, which are often more affordable alternatives to brand-name products.Another trend in the market is the growing popularity of online sales channels. Consumers in Cyprus are increasingly turning to online platforms to purchase OTC pharmaceutical products. This trend is driven by the convenience and accessibility of online shopping, as well as the availability of a wider range of products compared to brick-and-mortar stores. Online sales channels also offer consumers the opportunity to compare prices and read reviews before making a purchase.Local special circumstances in Cyprus also contribute to the development of the Other OTC Pharmaceuticals market. The country has a well-established healthcare system, with a high level of accessibility to pharmacies and healthcare professionals. This facilitates the distribution and sale of OTC pharmaceutical products, as consumers have easy access to expert advice and guidance. Additionally, the relatively small size of the market allows for a more personalized approach, with pharmacists often providing individualized recommendations to customers.Underlying macroeconomic factors also play a role in the development of the market. Cyprus has experienced steady economic growth in recent years, which has contributed to increased consumer spending power. This, in turn, has led to higher demand for OTC pharmaceutical products. Additionally, the aging population in Cyprus is driving the demand for OTC medications, as older individuals are more likely to experience health issues that can be managed with over-the-counter treatments.In conclusion, the Other OTC Pharmaceuticals market in Cyprus is developing in response to customer preferences for self-medication and convenience. The market is seeing an increase in product availability and variety, as well as the growing popularity of online sales channels. Local special circumstances, such as the well-established healthcare system and personalized approach, also contribute to the market's development. Underlying macroeconomic factors, including economic growth and an aging population, further drive the demand for OTC pharmaceutical products in Cyprus.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)